| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |